Change of Selection to Antihypertensive Drugs in Hypertensive Patients with Diabetes Mellitus: In Pohang . Gyeongju Primary Care Research Network.
10.4082/kjfm.2009.30.3.197
- Author:
Zu Young YUN
1
;
Dong Wook LEE
;
Hee Su JUNG
;
Ki Hm PARK
;
Sin Hyeong LEE
;
Jung Jae PARK
;
Dong Ik KIM
;
Jae Man KI
;
Kyung Rae CHO
;
Joon Seok SONG
;
Seok CHOI
;
Cheang Ho U
;
Tae Ho JUNG
;
Sook Heong JUNG
;
Sung Woo KIM
;
Ik KIM
Author Information
1. Department of Family Medicine, Dongguk University, College of Medicine, Gyeonju, Korea. fmleedu@lycos.co.kr
- Publication Type:Original Article
- Keywords:
Diabetes Mellitus;
Hypertension;
Angiotensin Converting Enzyme Inhibitors;
Angiotensin II Type 1 Receptor Blockers
- MeSH:
Angiotensin II Type 1 Receptor Blockers;
Angiotensin-Converting Enzyme Inhibitors;
Antihypertensive Agents;
Diabetes Mellitus;
Humans;
Hypertension;
Physicians, Family;
Prescriptions;
Primary Health Care
- From:Korean Journal of Family Medicine
2009;30(3):197-201
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Angiotensin converting enzyme inhibitors (ACEIs) or Angiotensin II type 1 receptor blockers (ARBs) are compelling indication drugs for hypertensive patients with diabetes mellitus. But prescription rate in 2005 year study of Pohang . Gyeongju area was only 30.8%. Therefore, a study on the change of prescription rate in the same area after 3 years was done. METHODS: During three months from January 2008, 152 hypertensive patients with diabetes mellitus on their prescribed antihypertensive medications by 9 family physicians in visiting order were analyzed. After the analysis, the infl uencing factors for such prescriptions were ascertained by directly visiting each physicians who prescribed them. RESULTS: A regimen of 16 antihypertensive agents were prescribed by these family physicians. Prescription count of ACEIs or ARBs was 101 cases (66.4%). ACEIs single therapy was 19 cases (12.5%), ACEIs combination therapy was 7 cases (4.6%), ARBs single therapy was 31 cases (20.4%) and ARBs combination therapy was 44 cases (28.9%). The ACEIs or ARBs which were selected by physicians that followed "compelling indication" was 5 (55.6%), "excellent reduce pressure effect" was 3 (33.3%) and "public relations of new medicine" was 1 (11.1%). CONCLUSION: In prescribing antihypertensive agents for patients with diabetes mellitus, selection of ACEIs or ARBs was increased from 30.8% to 66.4%. Education of recommended standard by participating in such study and developing of excellent new medicines may increase such change.
